Open AccessLevels of PSMA and Numbers of Positive Cells Determine Success of Radioligand Therapy
Author(s) -
Gary D. Luker
Publication year - 2020
Publication title -
radiology. imaging cancer
Language(s) - English
Resource type - Journals
ISSN - 2638-616X
DOI - 10.1148/rycan.2020204024
Subject(s) - prostate cancer , medicine , glutamate carboxypeptidase ii , radioligand , radiation therapy , cancer , cancer research , targeted therapy , prostate , oncology , cancer cell , metastasis , receptor